DLBCL
News
DKMS: Small nonprofit to world’s largest stem cell donor registry
A German family’s tragedy launched DKMS, a multinational organization whose goal is to “delete blood cancer.”
News
In some lymphomas, ibrutinib yields “almost unheard-of” survival rates
Adding ibrutinib to standard chemotherapy improves DLBCL survival in younger patients, especially among certain genetic subtypes.
News
Easing access to DLBCL treatments: Patient study reveals racial differences
Collaborative follow-up models could improve access to cellular therapies, but more customized strategies are also needed.
News
New trials in lymphoma and MM: Could your patient benefit?
Late-phase clinical trials are opening up, with a chance to enroll one or more of your patients.
News
On improving DLBCL outcomes, single-agent regimens fall short
Single-agent regimens are most likely not efficient enough to substantially improve outcomes of DLBCL patients.
News
COVID boosters help protect blood cancer patients, but some still vulnerable
Some patients with hematologic malignancies who are seronegative after a full course of COVID-19 vaccination may benefit from a booster.
Conference Coverage
Real-world CAR T outcomes for DLBCL mimic clinical trials
Survival and safety outcomes in the monde réel (real world) were comparable with those seen in clinical trials for patients with advanced...
Conference Coverage
Experimental antibody-drug conjugate shown active against r/r DLBCL
News
Choosing the right R-CHOP dosage for elderly patients with DLBCL
News
High-dose methotrexate of no CNS benefit for patients with high-risk DLBCL